Genotypic and phenotypic features of B-CLL tumors with wild-type ATM/TP53
Patient . | ATM gene . | TP53gene . | p53/MDM2/p21 induction . | Nearest VH/D/J gene . | % Homology . | Stage . | Th . |
---|---|---|---|---|---|---|---|
B-CLL47 | WT | WT | Normal | V4-34 | 95.5 | A | No |
D5-5 | |||||||
B-CLL48 | WT | WT | Normal | V1-03 | 81.9 | A | No |
D2-2 | |||||||
B-CLL13 | WT | WT | Normal | V3-30.3 | 99.6 | C | No |
D3-3/J4 | |||||||
B-CLL15 | WT | WT | Normal | V1-58 | 92.7 | B | No |
D6-6/J4 | |||||||
B-CLL19 | WT | WT | Normal | V3-30.3 | 89.9 | A | No |
D3-3 | |||||||
B-CLL49 | WT | WT | Normal | V5-11 | 95 | A | No |
D21-7/J4 | |||||||
B-CLL20 | WT | WT | Normal | V1-02 | 99.3 | C | C |
D3-22/J4 | |||||||
B-CLL50 | WT | WT | Normal | V1-12 | 95 | C | C |
B-CLL51 | WT | WT | Normal | V3-23 | 98.6 | A | No |
D4-17 | |||||||
B-CLL52 | WT | WT | Normal | V1-69 | 94.8 | A | No |
D3-16 | |||||||
B-CLL53 | WT | WT | Normal | V3-21 | 97.3 | B | No |
D3-9 | |||||||
B-CLL54 | WT | WT | Normal | V3-74 | 93.5 | C | F |
D5-12 | |||||||
B-CLL553-150 | WT | WT | Normal | V3-74 | 100 | C | E/C/F |
LOH | D3-10 | ||||||
B-CLL56 | WT | WT | Normal | V4-41 | 92.1 | A | No |
D1-7 | |||||||
B-CLL57 | WT | WT | Normal | V1-08 | 90 | A | No |
D3-10 | |||||||
B-CLL583-150 | WT | WT | Normal | V4-15 | 97.9 | C | E/C/F |
LOH | D5-24 | ||||||
B-CLL59 | WT | WT | Normal | V3-30.3 | 98.2 | B | C |
D3-3 | |||||||
B-CLL60 | WT | WT | Normal | V3-21 | 97.2 | C | C |
D4-4 | |||||||
B-CLL61 | WT | WT | Normal | V3-23 | 95 | A | No |
B-CLL68 | WT | WT | ND | V3-43 | 90 | A | No |
B-CLL62 | WT | WT | ND | V3-33 | 96.8 | A | No |
B-CLL63 | WT | WT | ND | V3-48 | 89.6 | C | F |
D3-9/J6 | |||||||
B-CLL29 | WT | WT | ND | V3-23 | 94.1 | A | No |
B-CLL11 | WT | WT | ND | VDJ ns | ns | C | C/CHOP |
B-CLL64 | WT | WT | ND | V1-2 | 99.5 | A | No |
D3-10 | |||||||
B-CLL10 | WT | WT | ND | V1-02 | 99.6 | B | C/P |
D3-3 | |||||||
B-CLL67 | WT | WT | ND | V4-39 | 95.3 | B | E/C |
D2-9 | |||||||
B-CLL65 | WT | WT | ND | V3-72 | 91.9 | A | C |
D3-9 |
Patient . | ATM gene . | TP53gene . | p53/MDM2/p21 induction . | Nearest VH/D/J gene . | % Homology . | Stage . | Th . |
---|---|---|---|---|---|---|---|
B-CLL47 | WT | WT | Normal | V4-34 | 95.5 | A | No |
D5-5 | |||||||
B-CLL48 | WT | WT | Normal | V1-03 | 81.9 | A | No |
D2-2 | |||||||
B-CLL13 | WT | WT | Normal | V3-30.3 | 99.6 | C | No |
D3-3/J4 | |||||||
B-CLL15 | WT | WT | Normal | V1-58 | 92.7 | B | No |
D6-6/J4 | |||||||
B-CLL19 | WT | WT | Normal | V3-30.3 | 89.9 | A | No |
D3-3 | |||||||
B-CLL49 | WT | WT | Normal | V5-11 | 95 | A | No |
D21-7/J4 | |||||||
B-CLL20 | WT | WT | Normal | V1-02 | 99.3 | C | C |
D3-22/J4 | |||||||
B-CLL50 | WT | WT | Normal | V1-12 | 95 | C | C |
B-CLL51 | WT | WT | Normal | V3-23 | 98.6 | A | No |
D4-17 | |||||||
B-CLL52 | WT | WT | Normal | V1-69 | 94.8 | A | No |
D3-16 | |||||||
B-CLL53 | WT | WT | Normal | V3-21 | 97.3 | B | No |
D3-9 | |||||||
B-CLL54 | WT | WT | Normal | V3-74 | 93.5 | C | F |
D5-12 | |||||||
B-CLL553-150 | WT | WT | Normal | V3-74 | 100 | C | E/C/F |
LOH | D3-10 | ||||||
B-CLL56 | WT | WT | Normal | V4-41 | 92.1 | A | No |
D1-7 | |||||||
B-CLL57 | WT | WT | Normal | V1-08 | 90 | A | No |
D3-10 | |||||||
B-CLL583-150 | WT | WT | Normal | V4-15 | 97.9 | C | E/C/F |
LOH | D5-24 | ||||||
B-CLL59 | WT | WT | Normal | V3-30.3 | 98.2 | B | C |
D3-3 | |||||||
B-CLL60 | WT | WT | Normal | V3-21 | 97.2 | C | C |
D4-4 | |||||||
B-CLL61 | WT | WT | Normal | V3-23 | 95 | A | No |
B-CLL68 | WT | WT | ND | V3-43 | 90 | A | No |
B-CLL62 | WT | WT | ND | V3-33 | 96.8 | A | No |
B-CLL63 | WT | WT | ND | V3-48 | 89.6 | C | F |
D3-9/J6 | |||||||
B-CLL29 | WT | WT | ND | V3-23 | 94.1 | A | No |
B-CLL11 | WT | WT | ND | VDJ ns | ns | C | C/CHOP |
B-CLL64 | WT | WT | ND | V1-2 | 99.5 | A | No |
D3-10 | |||||||
B-CLL10 | WT | WT | ND | V1-02 | 99.6 | B | C/P |
D3-3 | |||||||
B-CLL67 | WT | WT | ND | V4-39 | 95.3 | B | E/C |
D2-9 | |||||||
B-CLL65 | WT | WT | ND | V3-72 | 91.9 | A | C |
D3-9 |
B-CLLs 55 and 58 had 11q deletion and LOH acrossATM region.
For abbreviations, see Table 1.